Angiogenic effects of stromal cell-derived factor-1 (SDF-1/CXCL12) variants in vitro and the in vivo expressions of CXCL12 variants and CXCR4 in human critical leg ischemia

Journal of Vascular Surgery

Volumn 51, Issue 3, 2010, Pages 689-699

  Ho, Teik K ^a   Tsui, Janice ^a   Xu, Shiwen ^b   Leoni, Patricia ^b   Abraham, David J ^b   Baker, Daryll M ^a  

^a Vascular Unit   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; CASPASE 3; CHEMOKINE RECEPTOR CXCR4; MATRIGEL; METHYLENE BLUE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; STROMAL CELL DERIVED FACTOR 1;

ANGIOGENESIS; APOPTOSIS; ARTICLE; ATTENUATION; CELL COUNT; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CRITICAL LEG ISCHEMIA; ENDOTHELIUM CELL; GASTROCNEMIUS MUSCLE; GENE EXPRESSION REGULATION; GENE LOCATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LEG ISCHEMIA; MICROVASCULATURE; MUSCLE BIOPSY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; STAINING; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AGED; ANGIOGENESIS INDUCING AGENTS; APOPTOSIS; BIOPSY; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CXCL12; CRITICAL ILLNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; ISCHEMIA; LOWER EXTREMITY; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, CXCR4; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 77449143491     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2009.10.044     Document Type: Article

References (40)

1. Novo S., Coppola G., and Milio G. Critical limb ischemia: definition and natural history. Curr Drug Targets Cardiovasc Haematol Disord 4 (2004) 219-225
2. Ho T.K., Rajkumar V., Black C.M., Abraham D.J., and Baker D.M. Increased angiogenic response but deficient arteriolization and abnormal microvessel ultrastructure in critical leg ischemia. Br J Surg 93 (2006) 1368-1376
3. Ho T.K., Rajkumar V., Ponticos M., Leoni P., Black D.C., Abraham D.J., et al. Increased endogenous angiogenic response and hypoxia-inducible factor-1alpha in human critical limb ischemia. J Vasc Surg 43 (2006) 125-133
4. Ceradini D.J., and Gurtner G.C. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc Med 15 (2005) 57-63
5. Koshiba T., Hosotani R., Miyamoto Y., Ida J., Tsuji S., Nakajima S., et al. Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res 6 (2000) 3530-3535
6. Kryczek I., Lange A., Mottram P., Alvarez X., Cheng P., Hogan M., et al. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res 65 (2005) 465-472
7. Nagasawa T., Tachibana K., and Kawabata K. A CXC chemokine SDF-1/PBSF: a ligand for a HIV coreceptor, CXCR4. Adv Immunol 71 (1999) 211-228
8. Shirozu M., Nakano T., Inazawa J., Tashiro K., Tada H., Shinohara T., et al. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics 28 (1995) 495-500
9. Horuk R. Chemokine receptors. Cytokine Growth Factor Rev 12 (2001) 313-335
10. Ganju R.K., Brubaker S.A., Meyer J., Dutt P., Yang Y., Qin S., et al. The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem 273 (1998) 23169-23175
11. Han Y., Wang J., He T., and Ransohoff R.M. TNF-alpha down-regulates CXCR4 expression in primary murine astrocytes. Brain Res 888 (2001) 1-10
12. Popik W., Hesselgesser J.E., and Pitha P.M. Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway. J Virol 72 (1998) 6406-6413
13. Sotsios Y., Whittaker G.C., Westwick J., and Ward S.G. The CXC chemokine stromal cell-derived factor activates a Gi-coupled phosphoinositide 3-kinase in T lymphocytes. J Immunol 163 (1999) 5954-5963
14. Murdoch C., Monk P.N., and Finn A. Cxc chemokine receptor expression on human endothelial cells. Cytokine 11 (1999) 704-712
15. Kucia M., Ratajczak J., Reca R., Janowska-Wieczorek A., and Ratajczak M.Z. Tissue-specific muscle, neural and liver stem/progenitor cells reside in the bone marrow, respond to an SDF-1 gradient and are mobilized into peripheral blood during stress and tissue injury. Blood Cells Mol Dis 32 (2004) 52-57
16. Ratajczak M.Z., Majka M., Kucia M., Drukala J., Pietrzkowski Z., Peiper S., et al. Expression of functional CXCR4 by muscle satellite cells and secretion of SDF-1 by muscle-derived fibroblasts is associated with the presence of both muscle progenitors in bone marrow and hematopoietic stem/progenitor cells in muscles. Stem Cells 21 (2003) 363-371
17. Schioppa T., Uranchimeg B., Saccani A., Biswas S.K., Doni A., Rapisarda A., et al. Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med 198 (2003) 1391-1402
18. Staller P., Sulitkova J., Lisztwan J., Moch H., Oakeley E.J., and Krek W. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumeur suppressor pVHL. Nature 425 (2003) 307-311
19. Ades E.W., Candal F.J., Swerlick R.A., George V.G., Summers S., Bosse D.C., et al. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 99 (1992) 683-690
20. Kamal K., Du W., Mills I., and Sumpio B.E. Antiproliferative effect of elevated glucose in human microvascular endothelial cells. J Cell Biochem 71 (1998) 491-501
21. Oliver M.H., Harrison N.K., Bishop J.E., Cole P.J., and Laurent G.J. A rapid and convenient assay for counting cells cultured in microwell plates: application for assessment of growth factors. J Cell Sci 92 Pt 3 (1989) 513-518
22. Yamaguchi J., Kusano K.F., Masuo O., Kawamoto A., Silver M., Murasawa S., et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107 (2003) 1322-1328
23. Beckert S., Farrahi F., Aslam R.S., Scheuenstuhl H., Königrainer A., Hussain M.Z., et al. Lactate stimulates endothelial cell migration. Wound Repair Regen 14 (2006) 321-324
24. Xu S.W., Howat S.L., Renzoni E.A., Holmes A., Pearson J.D., Dashwood M.R., et al. Endothelin-1 induces expression of matrix-associated genes in lung fibroblasts through MEK/ERK. J Biol Chem 279 (2004) 23098-23103
25. Kleinman H.K., and Martin G.R. Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol 15 (2005) 378-386
26. Ponce M.L., Nomizu M., Delgado M.C., Kuratomi Y., Hoffman M.P., Powell S., et al. Identification of endothelial cell binding sites on the laminin gamma 1 chain. Circ Res 84 (1999) 688-694
27. Zukowska-Grojec Z., Karwatowska-Prokopczuk E., Rose W., Rone J., Movafagh S., Ji H., et al. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res 83 (1998) 187-195
28. Sobieszek A., and Small J.V. Effect of muscle and non-muscle tropomyosins in reconstituted skeletal muscle actomyosin. Eur J Biochem 118 (1981) 533-539
29. De la Luz S.M., Yang F., Narazaki M., Salvucci O., Davis D., Yarchoan R., et al. Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity. Blood 103 (2004) 2452-2459
30. Altenburg J.D., Broxmeyer H.E., Jin Q., Cooper S., Basu S., and Alkhatib G. A naturally occurring splice variant of CXCL12/stromal cell-derived factor 1 is a potent human immunodeficiency virus type 1 inhibitor with weak chemotaxis and cell survival activities. J Virol 81 (2007) 8140-8148
31. Crump M.P., Gong J.H., Loetscher P., Rajarathnam K., Amara A., Renzana-Seisdedos F., et al. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J 16 (1997) 6996-7007
32. Cuthbertson R.A., Hopper J.L., and Mandel T.E. Difference in effect of cultured fetal pancreas transplants on retinal and renal capillary basement membrane thickness in diabetic mice. Transplantation 48 (1989) 218-223
33. Naeser P., and Swenne I. Labelling of retinal capillaries in mice by repeated [3H]thymidine injections. Acta Ophthalmol (Copenh) 64 (1986) 9-11
34. Wickline K.M., and Fischer V.W. Incorporation of [3H]thymidine into myocardial capillary cells in streptozotocin-diabetic rats. Exp Mol Pathol 43 (1985) 135-141
35. Maurer H.R. Potential pitfalls of [3H]thymidine techniques to measure cell proliferation. Cell Tissue Kinet 14 (1981) 111-120
36. Vlahakis S.R., Villasis-Keever A., Gomez T., Vanegas M., Vlahakis N., and Paya C.V. G protein-coupled chemokine receptors induce both survival and apoptotic signaling pathways. J Immunol 169 (2002) 5546-5554
37. De P.B., and De Bleecker J.L. Beta-chemokine receptor expression in idiopathic inflammatory myopathies. Muscle Nerve 31 (2005) 621-627
38. Sasaki T., Fukazawa R., Ogawa S., Kanno S., Nitta T., Ochi M., et al. Stromal cell-derived factor-1alpha improves infarcted heart function through angiogenesis in mice. Pediatr Int 49 (2007) 966-971
39. Cipriani P., Franca M.A., Liakouli V., Pacini A., Manetti M., Marrelli A., et al. Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: pathogenetic implications. Arthritis Rheum 54 (2006) 3022-3033
40. Carr A.N., Howard B.W., Yang H.T., Eby-Wilkens E., Loos P., Varbanov A., et al. Efficacy of systemic administration of SDF-1 in a model of vascular insufficiency: support for an endothelium-dependent mechanism. Cardiovasc Res 69 (2006) 925-935